Literature DB >> 12663827

Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children.

Kader K Oguz1, Xavier Golay, Francesca B Pizzini, Catherine A Freer, Nevada Winrow, Rebecca Ichord, James F Casella, Peter C M van Zijl, Elias R Melhem.   

Abstract

Cerebral blood flow (CBF) was measured with continuous arterial spin-labeling perfusion magnetic resonance (MR) imaging in 14 children with sickle cell disease and seven control subjects. Mean CBF values were higher in patients (P <.005) than in control subjects in all cerebral artery territories. Three patients had decreased CBF in right anterior and middle cerebral artery territories compared with CBF on the left, and one patient had a profound decrease in CBF in all three territories in the right hemisphere. Baseline CBF was significantly decreased in territories seen as unaffected on conventional MR images and MR angiograms in four children with sickle cell disease. Copyright RSNA, 2003

Entities:  

Mesh:

Year:  2003        PMID: 12663827     DOI: 10.1148/radiol.2272020903

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  33 in total

Review 1.  Role of MR imaging in pediatric surgery.

Authors:  Raju Sharma; Shivanand Gamanagatti
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

2.  Continuous ASL perfusion fMRI investigation of higher cognition: quantification of tonic CBF changes during sustained attention and working memory tasks.

Authors:  Junghoon Kim; John Whyte; Jiongjiong Wang; Hengyi Rao; Kathy Z Tang; John A Detre
Journal:  Neuroimage       Date:  2006-01-19       Impact factor: 6.556

3.  Multi-parametric neuroimaging reproducibility: a 3-T resource study.

Authors:  Bennett A Landman; Alan J Huang; Aliya Gifford; Deepti S Vikram; Issel Anne L Lim; Jonathan A D Farrell; John A Bogovic; Jun Hua; Min Chen; Samson Jarso; Seth A Smith; Suresh Joel; Susumu Mori; James J Pekar; Peter B Barker; Jerry L Prince; Peter C M van Zijl
Journal:  Neuroimage       Date:  2010-11-20       Impact factor: 6.556

4.  Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx.

Authors:  Ze Wang; Geoffrey K Aguirre; Hengyi Rao; Jiongjiong Wang; María A Fernández-Seara; Anna R Childress; John A Detre
Journal:  Magn Reson Imaging       Date:  2007-09-10       Impact factor: 2.546

5.  Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA).

Authors:  John J Strouse; Christiane S Cox; Elias R Melhem; Hanzhang Lu; Michael A Kraut; Alexander Razumovsky; Kaleb Yohay; Peter C van Zijl; James F Casella
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

Review 6.  Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging.

Authors:  Ronald L Wolf; John A Detre
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

7.  Functional and anatomical evidence of cerebral tissue hypoxia in young sickle cell anemia mice.

Authors:  Lindsay S Cahill; Lisa M Gazdzinski; Albert Ky Tsui; Yu-Qing Zhou; Sharon Portnoy; Elaine Liu; C David Mazer; Gregory Mt Hare; Andrea Kassner; John G Sled
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

8.  Hemodynamic responses to visual stimulation in children with sickle cell anemia.

Authors:  Ping Zou; Kathleen J Helton; Matthew Smeltzer; Chin-Shang Li; Heather M Conklin; Amar Gajjar; Winfred C Wang; Russell E Ware; Robert J Ogg
Journal:  Brain Imaging Behav       Date:  2011-12       Impact factor: 3.978

Review 9.  Applications of arterial spin labeled MRI in the brain.

Authors:  John A Detre; Hengyi Rao; Danny J J Wang; Yu Fen Chen; Ze Wang
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

10.  Determination of spin compartment in arterial spin labeling MRI.

Authors:  Peiying Liu; Jinsoo Uh; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2011-01       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.